JPS5053520A - - Google Patents
Info
- Publication number
- JPS5053520A JPS5053520A JP49105958A JP10595874A JPS5053520A JP S5053520 A JPS5053520 A JP S5053520A JP 49105958 A JP49105958 A JP 49105958A JP 10595874 A JP10595874 A JP 10595874A JP S5053520 A JPS5053520 A JP S5053520A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7333647A FR2243684B1 (enExample) | 1973-09-19 | 1973-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5053520A true JPS5053520A (enExample) | 1975-05-12 |
Family
ID=9125267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49105958A Pending JPS5053520A (enExample) | 1973-09-19 | 1974-09-13 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3957853A (enExample) |
| JP (1) | JPS5053520A (enExample) |
| BE (1) | BE820072A (enExample) |
| DE (1) | DE2444532A1 (enExample) |
| ES (1) | ES430174A1 (enExample) |
| FR (1) | FR2243684B1 (enExample) |
| GB (1) | GB1432325A (enExample) |
| LU (1) | LU70941A1 (enExample) |
| NL (1) | NL7412427A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007509973A (ja) * | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | 増強された吸収のための組成物および投与形態物 |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2611501B1 (fr) * | 1987-03-04 | 1991-12-06 | Corbiere Jerome | Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention |
| US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
| JP3382159B2 (ja) * | 1998-08-05 | 2003-03-04 | 株式会社東芝 | 情報記録媒体とその再生方法及び記録方法 |
| US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
| FR2796551B1 (fr) * | 1999-07-23 | 2003-07-25 | Lipha | Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant |
| FR2796940B1 (fr) * | 1999-07-26 | 2005-04-08 | Lipha | Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant |
| US20060034922A1 (en) * | 2000-11-03 | 2006-02-16 | Andrx Labs, Llc | Controlled release metformin compositions |
| US6866866B1 (en) * | 2000-11-03 | 2005-03-15 | Andrx Labs, Llc | Controlled release metformin compositions |
| US6790459B1 (en) | 2000-11-03 | 2004-09-14 | Andrx Labs, Llc | Methods for treating diabetes via administration of controlled release metformin |
| JP2004531463A (ja) | 2000-11-03 | 2004-10-14 | アンドルクス ラブス，エルエルシー | 徐放メトホルミン組成物 |
| AU2003241537A1 (en) * | 2002-05-23 | 2003-12-12 | Andrx Corporation | Biguanide formulations |
| ES2529180T3 (es) | 2002-09-20 | 2015-02-17 | Andrx Labs Llc | Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona |
| US20050051922A1 (en) * | 2002-09-20 | 2005-03-10 | Avinash Nangia | Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
| US20050048119A1 (en) * | 2002-09-20 | 2005-03-03 | Avinash Nangia | Controlled release composition with semi-permeable membrane and poloxamer flux enhancer |
| WO2008093984A1 (en) | 2007-01-29 | 2008-08-07 | Hanall Pharmaceutical Company. Ltd | N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| JP5292404B2 (ja) * | 2007-09-21 | 2013-09-18 | ハンオル バイオファーマ カンパニー，リミテッド | Ｎ，ｎ−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物 |
| JP5551691B2 (ja) | 2008-06-26 | 2014-07-16 | ラボラトリオス シラネス、エセ．ア．デ セ．べ． | 血糖制御のための新規グリシン酸メトホルミン塩 |
| US20110021634A1 (en) | 2009-06-18 | 2011-01-27 | Patel Pranav Dushyant | Processes for preparing metformin hydrochloride |
| WO2011049400A2 (ko) * | 2009-10-23 | 2011-04-28 | 한올바이오파마주식회사 | N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물 |
| CN101691344B (zh) * | 2009-10-26 | 2012-10-17 | 漆又毛 | 一种二甲双胍酸式复盐化合物及制备方法 |
| PT2576524T (pt) | 2010-05-26 | 2017-11-17 | Vtv Therapeutics Llc | Resumo |
| US8440723B2 (en) * | 2011-05-11 | 2013-05-14 | Banavara L. Mylari | Metformin salts of salicylic acid and its congeners |
| IN2014DN09554A (enExample) | 2012-05-17 | 2015-07-17 | Transtech Pharma Llc | |
| US11510886B2 (en) | 2016-09-30 | 2022-11-29 | Laboratorios Silanes, S.A. De C.V. | Metformin amino acid compounds and methods of using the same |
| MX2019003725A (es) | 2016-09-30 | 2019-08-12 | Laboratorios Silanes S A De C V | Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma. |
| CN107118130A (zh) * | 2017-05-11 | 2017-09-01 | 杜剑平 | 一类治疗肿瘤的药物化合物及其应用 |
| CA3093025A1 (en) | 2018-06-12 | 2019-12-19 | Vtv Therapeutics Llc | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
| US12391658B2 (en) | 2020-02-18 | 2025-08-19 | Vtv Therapeutics Llc | Sulfoxide and sulfone glucokinase activators and methods of use thereof |
| CN115073331A (zh) * | 2021-03-15 | 2022-09-20 | 中国医学科学院药物研究所 | 二甲双胍肉桂酸盐一水合物及制备方法和其组合物与用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE568513A (enExample) * | ||||
| FR1295304A (fr) * | 1956-05-07 | 1962-06-08 | Equilibre Biolog L | Nouveau sel de l'acide acétyl-salicylique et son procédé de préparation |
| US2983750A (en) * | 1959-07-03 | 1961-05-09 | Bristol Myers Co | Tris methylammonium salicylate salts |
| GB883331A (en) * | 1959-08-28 | 1961-11-29 | Mead Johnson & Co | Stable water-soluble acetylsalicylic acid derivative |
-
1973
- 1973-09-19 FR FR7333647A patent/FR2243684B1/fr not_active Expired
-
1974
- 1974-09-11 US US05/505,015 patent/US3957853A/en not_active Expired - Lifetime
- 1974-09-13 JP JP49105958A patent/JPS5053520A/ja active Pending
- 1974-09-17 GB GB4043674A patent/GB1432325A/en not_active Expired
- 1974-09-17 LU LU70941A patent/LU70941A1/xx unknown
- 1974-09-18 DE DE19742444532 patent/DE2444532A1/de active Pending
- 1974-09-18 BE BE148666A patent/BE820072A/xx unknown
- 1974-09-18 ES ES430174A patent/ES430174A1/es not_active Expired
- 1974-09-19 NL NL7412427A patent/NL7412427A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007509973A (ja) * | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | 増強された吸収のための組成物および投与形態物 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2243684A1 (enExample) | 1975-04-11 |
| DE2444532A1 (de) | 1975-03-27 |
| US3957853A (en) | 1976-05-18 |
| NL7412427A (nl) | 1975-03-21 |
| FR2243684B1 (enExample) | 1977-01-28 |
| GB1432325A (en) | 1976-04-14 |
| ES430174A1 (es) | 1976-10-16 |
| LU70941A1 (enExample) | 1975-03-06 |
| BE820072A (fr) | 1975-01-16 |